The goal of this program is to define the functions of coronavirus replicase gene proteins during virus infection. The mouse hepatitis virus (MHV) replicase is translated from the positive strand RNA genome as an 800 kDa polyprotein, and processed by three viral proteinases to yield 16 mature replicase proteins (nsp1-16), that likely mediate replication complex formation and RNA synthesis, in addition to predicted roles in virus host interaction and pathogenesis. The amino-terminal replicase proteins (nsp1, nsp2, and nsp3) comprise a cassette of group specific proteins that are related by organization, mechanism of proteolytic processing, and group-specific evolution. Neither nsp1 (p28) nor nsp2 (p65) has known functions, while nsp3 (p210) is predicted to be a multifunctional protein that contains two known papain-like proteinases (PLP1 and PLP2) as well as other domains with possible functions in RNA synthesis and replication complex formation. However, apart from in vitro studies of nsp3 proteinase function and determinants, nothing is known of the functions of nsp 3 or its domains during virus infection. The three integrated Specific Aims of this proposal will use reverse-genetic and biochemical studies to define the functions of MHV nsp1, nsp2 and nsp3 in replicase protein processing and viral RNA synthesis during MHV infection in culture. These experiments will result in a comprehensive understanding of nsp1, nsp2 and nsp3 roles in replication, will identify potential targets for interference with virus replication, and provide the foundation for future studies of replicase protein functions in pathogenesis and disease. Finally, similarities between MHV and SARS-CoV in the replicase indicate that the results may have applicability to understanding the genetics and functions of replicase proteins of that important human pathogen.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026603-19
Application #
7342064
Study Section
Virology - B Study Section (VIRB)
Program Officer
Park, Eun-Chung
Project Start
1991-09-30
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
19
Fiscal Year
2008
Total Cost
$285,561
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Athmer, Jeremiah; Fehr, Anthony R; Grunewald, Matthew et al. (2017) In Situ Tagged nsp15 Reveals Interactions with Coronavirus Replication/Transcription Complex-Associated Proteins. MBio 8:
St John, Sarah E; Anson, Brandon J; Mesecar, Andrew D (2016) X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus. Sci Rep 6:25961
Mounce, Bryan C; Cesaro, Teresa; Moratorio, Gonzalo et al. (2016) Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J Virol 90:9683-9692
St John, Sarah E; Tomar, Sakshi; Stauffer, Shaun R et al. (2015) Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS). Bioorg Med Chem 23:6036-48
Smith, Everett Clinton; Case, James Brett; Blanc, Hervé et al. (2015) Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity. J Virol 89:6418-26
Tomar, Sakshi; Johnston, Melanie L; St John, Sarah E et al. (2015) Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. J Biol Chem 290:19403-22
St John, Sarah E; Therkelsen, Matthew D; Nyalapatla, Prasanth R et al. (2015) X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design. Bioorg Med Chem Lett 25:5072-7
Agnihothram, Sudhakar; Yount Jr, Boyd L; Donaldson, Eric F et al. (2014) A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5:e00047-14
Deng, Xufang; StJohn, Sarah E; Osswald, Heather L et al. (2014) Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance. J Virol 88:11886-98
Jacobs, Jon; Grum-Tokars, Valerie; Zhou, Ya et al. (2013) Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL pr J Med Chem 56:534-46

Showing the most recent 10 out of 28 publications